Home/Filings/4/0001437749-23-001797
4//SEC Filing

Schulz Marcus 4

Accession 0001437749-23-001797

CIK 0000834365other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 7:00 PM ET

Size

5.1 KB

Accession

0001437749-23-001797

Insider Transaction Report

Form 4
Period: 2023-01-23
Schulz Marcus
Vice President, Global Sales
Transactions
  • Sale

    Common Stock

    2023-01-23$25.02/sh1,000$25,02043,437 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.01 to $25.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

BIOLIFE SOLUTIONS INC

CIK 0000834365

Entity typeother

Related Parties

1
  • filerCIK 0001812702

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:00 PM ET
Size
5.1 KB